Skip to main contentSkip to navigation
Sirius Investors
Epigenomics AG

Epigenomics AG

EPGNF
OTCHealthcare

EPGNF Financial Statements & Analysis

Complete financial statements for EPGNF including income statement, balance sheet, and cash flow statement. Analyze EPGNF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
-8.6%
Net Income
65.3%
Gross Margin
4.6%
Operating Margin
64.0%

Balance Sheet

Current Ratio
1121.5%
Debt to Equity
383769.3%
Asset Turnover
1.1%

Cash Flow

Operating Cash Flow
41.0%
Net Cash Flow
51.6%
Free Cash Flow
45.7%
Cash Flow to Debt
38.4%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q3 '23TTM Q4 '23ChangeImpact
Revenue371.11K339.23K8.6%
Gross Profit295.16K282.31K4.4%
Operating Income-12.71M-4.18M67.1%
Net Income-12.85M-4.46M65.3%
EPS-3.80-1.3165.6%
EBITDA-10.17M-3.61M64.5%
Gross Margin79.53%83.22%4.6%
Operating Margin-3423.82%-1231.19%64.0%
Net Income Margin-3462.48%-1315.79%62.0%
R&D Expenses3.91M2.86M26.7%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q4 '23TTM Q3 '23TTM Q2 '23TTM Q1 '23TTM Q4 '22
Revenue339.23K371.11K448.00K
Gross Profit282.31K295.16K343.00K
Operating Income-4.18M-12.71M-16.42M
Net Income-4.46M-12.85M-16.29M
EPS-1.31-3.80-2.46
EBITDA-3.61M-10.17M-14.04M
Gross Margin83.22%79.53%76.56%
Operating Margin-1231.19%-3423.82%-3665.18%
Net Income Margin-1315.79%-3462.48%-3636.16%
R&D Expenses2.86M3.91M5.02M

Our detailed financial analysis helps investors understand EPGNF's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track EPGNF's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into EPGNF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Epigenomics AG (EPGNF) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors